Serum protein fingerprint of patients with pancreatic cancer by SELDI technology

• Published in: Chinese journal of cancer research Vol. 20; no. 3; pp. 171 - 176
• Main Authors: Ma, Ning, Ge, Chun-lin, Luan, Feng-ming, Yao, Dian-bo, Hu, Chao-jun, Li, Ning, Liu, Yong-feng
• Format: Journal Article
• Language: English
• Published: Heidelberg Chinese Anti-Cancer Association 01.09.2008; Department of General Surgery,the First Affiliated Hospital,China Medical University,Shenyang 110001,China%Peking Union Medical College Hospitals,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China
• Subjects: Medicine; Medicine & Public Health; Biological markers; SELDI; Pancreatic cancer; R735.9; Proteomic
• ISSN: 1000-9604; 1993-0631
• DOI: 10.1007/S11670-008-0171-4

Objective To study the serum protein fingerprint of patients with pancreatic cancer and to screen for protein molecules closely related to pancreatic cancer during the onset and progression of the disease using surface-enhanced laser desorption and ionization time of fight mass spectrometry (SELDI-TOF-MS). Methods Serum samples from 20 pancreatic cancers, 20 healthy volunteers and 18 patients with other pancreatic diseases. WCX magnetic beans and PBSII-C protein chips reader (Ciphergen Biosystems Ins.) were used. The protein fingerprint expression of all the Serum samples and the resulting profiles between cancer and normal were analyzed with Biomarker Wizard system. Results A group of proteomic peaks were detected. Four differently expressed potential biomarkers were identified with the relative molecular weights of 5705 Da, 4935 Da, 5318 Da and 3243 Da. Among them, two proteins with m/z5705, 5318Da down-regulated, and two proteins with m/z 4935, 3243 Da were up-regulated in pancreatic cancers. Conclusion SELDI technology can be used to screen significant proteins of differential expression in the serum of pancreatic cancer patients. These different proteins could be specific biomarkers of the patients with pancreatic cancer in the serum and have the potential value of further investigation.